1. Home
  2. ANTX vs NXPL Comparison

ANTX vs NXPL Comparison

Compare ANTX & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

N/A

Current Price

$1.10

Market Cap

30.1M

Sector

Health Care

ML Signal

N/A

Logo NextPlat Corp

NXPL

NextPlat Corp

N/A

Current Price

$0.61

Market Cap

25.6M

ML Signal

N/A

Company Overview

Basic Information
Metric
ANTX
NXPL
Founded
2017
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
30.1M
25.6M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
ANTX
NXPL
Price
$1.10
$0.61
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$2.00
N/A
AVG Volume (30 Days)
61.1K
176.0K
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$57,151,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.01
$0.43
52 Week High
$1.55
$2.30

Technical Indicators

Market Signals
Indicator
ANTX
NXPL
Relative Strength Index (RSI) 50.83 44.90
Support Level $1.03 $0.58
Resistance Level $1.23 $0.70
Average True Range (ATR) 0.08 0.06
MACD 0.00 0.00
Stochastic Oscillator 55.00 18.50

Price Performance

Historical Comparison
ANTX
NXPL

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.

About NXPL NextPlat Corp

NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.

Share on Social Networks: